Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

RadNet, Inc. - Common Stock (NQ: RDNT )

50.45 +1.44 (+2.94%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about RadNet, Inc. - Common Stock

< Previous 1 2 3 4 Next >
Benzinga's Top Ratings Upgrades, Downgrades For March 31, 2023
Via Benzinga
Analyst Upgrades This Radiology Stock, Expects Promising 2023 Ahead
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2023
Via Benzinga
RadNet Forecasts Lower Profits In 2022 Due To Rising Costs, Labor Shortage
Via Benzinga
RadNet Q1 Earnings Exceed Expectations, Revises FY22 Guidance Levels Upwards
Via Benzinga
Recap: RadNet Q4 Earnings
RadNet (NASDAQ:RDNT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings RadNet... 
Via Benzinga
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Earnings Scheduled For March 1, 2022
Companies Reporting Before The Bell • Precigen (NASDAQ:PGEN) is expected to report earnings for its fourth quarter. • TG Therapeutics (NASDAQ:TGTX) is estimated... 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
Why NLS Pharmaceutics Shares Tumbled Over 66%; Here Are 68 Biggest Movers From Yesterday
Gainers PepGen Inc. (NASDAQ: PEPG) jumped 110.2% to close at $10.93 after the company announced results from its Phase 1 healthy volunteer trial of PGN-EDO51 for Duchenne Muscular Dystrophy. The trial... 
Via Benzinga
7 Micro-Cap Stocks to Buy and Hold for the Next 10 Years
Finding micro-cap stocks to buy requires a bit of everything, including patience. Today's plan is to pick from the top of the IWC ETF. 
Via InvestorPlace
Why Prothena Corporation Shares Are Trading Higher By 76%, Here Are 53 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
RadNet Earnings Conference Call Is Coming Up, Here's What You Need To Know
RadNet (NASDAQ:RDNT) will host a conference call at 10:30 AM ET on May 9, 2022, to discuss Q1 2022 earnings results. How to Attend RadNet (RDNT) Conference Call Follow this link to access the live... 
Via Benzinga
RadNet's Return on Invested Capital Overview
Pulled from Benzinga Pro data, RadNet (NASDAQ:RDNT) showed a loss in earnings since Q3, totaling $1.31 million. Sales, on the other hand, increased by 0.14% to $333.15 million... 
Via Benzinga
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. 
Via Benzinga
Earnings Scheduled For May 9, 2022
Companies Reporting Before The Bell • Atlantica Sustainable (NASDAQ:AY) is likely to report quarterly loss at $0.08 per share on revenue of $277.90 million. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Avenue Therapeutics (NASDAQ:ATXI) shares rose 102.3% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $14.3... 
Via Benzinga
RadNet Q4 Topline, BottomLine Hit Due To Omicron Surge, FY22 Guidance In-Line With Consensus
RadNet Inc (NASDAQ: RDNT) reports Q4 FY21 revenue of $333.2 million, +8% Y/Y, missing the consensus of $348.34 million. Aggregate procedural volumes increased 11.4%;... 
Via Benzinga
Preview: RadNet's Earnings
RadNet (NASDAQ:RDNT) is set to give its latest quarterly earnings report on Tuesday, 2022-03-01. Here's what investors need to know before the announcement. Analysts estimate that... 
Via Benzinga
RadNet, inc (RDNT) Q3 2021 Earnings Call Transcript
RDNT earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
RadNet Q3 EPS Beat Estimates Despite Certain COVID-19 Related Challenges; Raises FY21 EBITDA Outlook
RadNet Inc (NASDAQ: RDNT) reports Q3 revenue of $332.7 million, +14% Y/Y, missing the consensus of $340.68 million. Aggregate procedural volumes increased 15.6%; Same-... 
Via Benzinga
Exposures COVID-19
Earnings Scheduled For November 8, 2021
Companies Reporting Before The Bell • Privia Health Group (NASDAQ:PRVA) is projected to report quarterly loss at $0.11 per share on revenue of $215.14 million. •... 
Via Benzinga
Cramer Likes American Eagle Outfitters And These 2 Pharma Stocks
On CNBC’s “ 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares jumped 33.7% to close at $3.37 on Monday after the company announced plan to expand product portfolio with introduction of... 
Via Benzinga
38 Stocks Moving In Monday's Mid-Day Session
Gainers NanoVibronix, Inc. (NASDAQ: NAOV) shares climbed 34.5% to $3.3900 after the company announced plan to expand product portfolio with introduction of Painshield relief for... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 12, 2021
Upgrades According to Northland Capital Markets, the prior rating for Points International Ltd 
Via Benzinga
RadNet, inc (RDNT) Q2 2021 Earnings Call Transcript
RDNT earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
RadNet Q2 Earnings Top Consensus On Recovery Of Procedural Volumes, Raises FY21 Guidance
RadNet Inc (NASDAQ: RDNT) reports Q2 revenue of $333.9 million, up 75.2% Y/Y, beating the consensus of $325.09 million and adjusted EBITDA of $56.6 million... 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.